SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number

[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number PART I. FINANCIAL INFORMATION Item 1.] [CERTIFICATE OF AMENDMENT AND CERTIFICATE OF CHANGE EX-3.1 3 v202562_ex3-1.htm] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Michael H. Lan, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer EX-32.1 37 v202562_ex32-1.htm] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Michael H. Lan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 38 v202562_ex32-2.htm]

By | 2016-03-01T05:43:36+00:00 November 15th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL INFORMATION Item 1. Financial Statements 4nsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4nsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [CERTIFICATE OF AMENDMENT AND CERTIFICATE OF CHANGE v202562_ex3-1.htm 3 EX-3.1] [CERTIFICATION I, Weibing Lu, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Michael H. Lan, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer v202562_ex32-1.htm 37 EX-32.1] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer (Principal Financial and Accounting Officer) v202562_ex32-2.htm 38 EX-32.2]

By | 2016-02-05T03:56:37+00:00 November 15th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL INFORMATION Item 1. Financial Statements 4nsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4nsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [CERTIFICATE OF AMENDMENT AND CERTIFICATE OF CHANGE v202562_ex3-1.htm 3 EX-3.1] [CERTIFICATION I, Weibing Lu, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Michael H. Lan, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer v202562_ex32-1.htm 37 EX-32.1] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer (Principal Financial and Accounting Officer) v202562_ex32-2.htm 38 EX-32.2]

By | 2016-02-05T03:55:47+00:00 November 15th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[SKYSTAR ANNOUNCES UPDATE XI'AN, CHINA – September 7, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Acquisition in Hubei Province The Company completed acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010. Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, will contribute about $4 million to $6 million in revenue]

By | 2016-03-01T05:46:01+00:00 September 7th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: SKYSTAR ANNOUNCES UPDATE XI’AN, CHINA – September 7,

[SKYSTAR ANNOUNCES UPDATE XI'AN, CHINA – September 7, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Acquisition in Hubei Province The Company completed acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010. Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, will contribute about $4 million to $6 million in revenue]

By | 2016-03-01T05:47:11+00:00 September 7th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[SKYSTAR ANNOUNCES UPDATE XI'AN, CHINA September 7, 2010 -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Acquisition in Hubei Province Thempanympleted acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010.Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, willntributeout $4 million to $6 million in revenuein a normalized full]

By | 2016-02-05T03:59:07+00:00 September 7th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar